Urokinase receptor - Wikipedia
The Urokinase receptor, also known as urokinase plasminogen activator surface receptor (uPAR) or CD87 (Cluster of Differentiation 87), is a protein encoded in humans by the PLAUR gene.
CD87 (urokinase-type plasminogen activator receptor), function and ...
2003年12月11日 · The analysis of CD87 (urokinase-type plasminogen activator receptor – uPAR) expression has a potential role in the diagnostic or prognostic work-up of several …
尿激酶纤溶酶原激活物受体（CD87）：旧的东西，新的东西 …
CD87是尿激酶纤溶酶原激活剂（uPA）广泛表达的受体，在调节细胞表面纤溶酶原激活中起关键作用。 越来越多的证据表明，CD87参与多种生理和病理过程的调控，包括细胞粘附，细胞运 …
uPAR/CD87：肿瘤微环境中的‘多面手’ - 知乎专栏
uPAR（urokinase-type plasminogen activator receptor），即 尿激酶型纤溶酶原激活剂 受体，是一种具有广泛生物学功能的膜蛋白受体。 其编码基因位于人类染色体19q13.3-13.4上，主要功 …
CD87 as a marker for terminal granulocytic maturation ... - PubMed
CD87 is expressed on granulocytes at the band and segmented neutrophil stage of development and can be used to study normal and abnormal granulopoiesis.
CD87-targeted BiTE and CAR-T cells potently inhibit invasive
CD87×CD3 BiTE and CD87 CAR/IL-12 T-cells showed antigenic specificity and exerted satisfactory cytotoxic effects, decreasing tumor cell proliferation in vitro and reducing existing …
Urokinase Receptor (uPAR, CD87) Is a Platelet Receptor Important …
1999年6月29日 · In the present report, we provide evidence that uPAR (CD87) is an important receptor for platelet kinetics, activation, and endothelium binding associated with inflammation. …
CD87 plays a role in cellular interaction, cell migration, and inflammatory response. Surface expression of this antigen has not been adequately studied on bone marrow granulocytes, and …
CD87用于急性髓细胞白血病预后判断的临床研究
目的:探讨急性髓细胞白血病(aml)细胞尿激酶型纤溶酶原激活物受体cd87(upar)的表达及其在诊断急性白血病分型、指导预测预后方面的意义.方法:应用流式细胞术(fcm)检测了41例初治的aml患 …
尿激酶受体（CD87）突变体在细胞上表达的变化 ... - X-MOL
尿激酶型纤溶酶原激活剂受体（uPAR，CD87）是糖基磷脂酰肌醇（GPI）锚定的蛋白，包含三个同源的Ly-6结构域，通过直接结合细胞外基质蛋白玻连蛋白（VN）介导整联蛋白独立的细胞 …
- 某些结果已被删除